The predictive effect of primary tumour location in the treatment of metastatic colorectal cancer: a Canadian consensus statement.
| Autor: | Abrahao ABK; Department of Oncology, Sunnybrook Health Sciences Centre, Toronto, ON., Karim S; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON., Colwell B; Division of Medical Oncology, Dalhousie University, Halifax, NS., Berry S; Department of Oncology, Sunnybrook Health Sciences Centre, Toronto, ON., Biagi J; Department of Oncology, Queen's University, Kingston, ON. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current oncology (Toronto, Ont.) [Curr Oncol] 2017 Dec; Vol. 24 (6), pp. 390-400. Date of Electronic Publication: 2017 Dec 20. |
| DOI: | 10.3747/co.24.3757 |
| Abstrakt: | In recently published data, the predictive value of primary tumour location for the treatment of metastatic colorectal cancer with available biologic therapies has been explored. Recognizing the potential effect of those data on clinical practice, we convened a meeting of Canadian experts who treat metastatic colorectal cancer to develop a set of national, evidence-based treatment guidelines based on primary tumour location. This report summarizes the relevant evidence and presents the consensus recommendations of those experts. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|